Professor Peter Hoffmann is Vice President of the Australasian Proteomics Society, Conference Chair for the National Meeting of the Australasian Proteomics Society, and is Treasurer of the international Human Proteome Organisation (HUPO). For ten years, Peter’s research has delved into the identification of low abundant proteins and the mapping of their posttranslational modifications and their use as potential biomarkers for early detection of diseases, one of the biggest challenges in proteomics. He is leader in the field of Mass Spectrometry Imaging and his research group was the first to use this technology in Australia. He has experience transforming research into industry-relevant outcomes, recently forming Onco DX to... Read more
About me
Professor Peter Hoffmann is Vice President of the Australasian Proteomics Society, Conference Chair for the National Meeting of the Australasian Proteomics Society, and is Treasurer of the international Human Proteome Organisation (HUPO). For ten years, Peter’s research has delved into the identification of low abundant proteins and the mapping of their posttranslational modifications and their use as potential biomarkers for early detection of diseases, one of the biggest challenges in proteomics. He is leader in the field of Mass Spectrometry Imaging and his research group was the first to use this technology in Australia. He has experience transforming research into industry-relevant outcomes, recently forming Onco DX to commercialise patented biomarkers for the early detection of ovarian and gastric cancer.
About me
Doctor of Philosophy Saarland University
University Saarland
Research
Excludes commercial-in-confidence projects.
Nanoparticle regulation of DNA replication and repair pathways, ARC - Discovery Projects, 21/01/2019 - 20/01/2022
Ovarian Blood Markers of Ovarian Cancer (phase 1 transfer in), Ovarian Cancer Research Foundation Inc, 04/12/2017 - 30/06/2018
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2019 |
2
1
|
| 2017 |
9
7
|
| Year | Output |
|---|---|
| 2019 |
|
| 2019 |
Open access
3
1
2
|
| 2019 |
|
| 2019 |
Open access
3
2
9
|
| 2019 |
|
| 2019 |
9
|
| 2019 |
Open access
|
| 2019 |
1
1
|
| 2019 |
|
| 2019 |
Open access
2
2
40
|
| 2018 |
Open access
7
5
1
|
| 2018 |
Open access
3
|
| 2018 |
Open access
3
4
17
|
| 2018 |
3
1
2
|
| 2017 |
7
7
2
|
| 2017 |
Open access
2
3
|
| 2017 |
7
8
1
|
| 2017 |
1
1
2
|
| 2017 |
Open access
10
8
|
| 2016 |
21
19
5
|
| 2016 |
Open access
5
5
1
|
| 2016 |
Open access
46
47
7
|
| 2016 |
Open access
16
16
|
| 2016 |
11
8
10
|
| 2016 |
8
8
10
|
| 2016 |
Open access
13
12
1
|
| 2016 |
Open access
18
18
12
|
| 2016 |
Open access
11
10
3
|
| 2016 |
Open access
3
3
1
|
| 2016 |
Open access
4
4
2
|
| 2016 |
Open access
14
15
1
|
| 2016 |
Open access
6
3
7
|
| 2015 |
Open access
11
13
1
|
| 2015 |
48
44
|
| 2015 |
Open access
|
| 2015 |
Open access
12
11
1
|
| 2015 |
Open access
44
42
11
|
| 2015 |
Open access
33
42
6
|
| 2015 |
Open access
37
37
|
| 2015 |
24
22
1
|
| 2015 |
5
5
10
|
| 2015 |
Open access
6
4
2
|
| 2014 |
Open access
35
33
66
|
| 2014 |
29
30
31
|
| 2014 |
Open access
10
11
|
| 2014 |
Open access
|
| 2014 |
5
5
1
|
| 2014 |
10
9
1
|
| 2013 |
20
17
|
| 2013 |
37
38
2
|
| 2013 |
Open access
42
38
|
| 2013 |
34
1
|
| 2013 |
Open access
7
3
|
| 2013 |
Open access
32
31
|
| 2013 |
29
25
|
| 2013 |
Open access
33
27
1
|
| 2012 |
Open access
|
| 2012 |
Open access
35
33
3
|
| 2012 |
8
7
|
| 2012 |
|
| 2012 |
33
33
4
|
| 2012 |
|
| 2012 |
23
18
1
|
| 2012 |
19
19
|
| 2012 |
2
2
|
| 2012 |
3
|
| 2012 |
23
21
1
|
| 2012 |
Open access
22
18
|
| 2012 |
Open access
6
|
| 2012 |
Open access
11
12
3
|
| 2012 |
Open access
16
14
|
| 2011 |
45
38
|
| 2011 |
8
4
|
| 2011 |
Open access
62
60
|
| 2011 |
Open access
6
5
|
| 2011 |
13
14
|
| 2011 |
7
7
|
| 2011 |
Open access
43
44
|
| 2010 |
5
5
6
|
| 2010 |
3
|
| 2010 |
78
75
3
|
| 2010 |
48
42
|
| 2010 |
Open access
61
58
|
| 2009 |
12
12
|
| 2009 |
8
8
|
| 2009 |
Open access
24
22
|
| 2009 |
18
17
|
| 2009 |
21
20
|
| 2009 |
29
25
|
| 2009 |
25
22
|
| 2009 |
4
4
|
| 2009 |
22
22
|
| 2008 |
8
10
|
| 2008 |
Open access
60
54
|
| 2008 |
Open access
|
| 2008 |
9
|
| 2008 |
Open access
67
53
|
| Year | Output |
|---|---|
| 2016 |
|
| 2016 |
1
1
|
| 2015 |
|
| 2013 |
|
| 2012 |
1
|
| 2011 |
1
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Agricultural Research Service | UNITED STATES |
| Australian Federal Police | AUSTRALIA |
| Boehringer Ingelheim Pharma GmbH & Co. KG | GERMANY |
| Bruker | AUSTRALIA |
| Chris O'Brien Lifehouse | AUSTRALIA |
| Coopers Brewery | AUSTRALIA |
| CSIRO Australia (Commonwealth Scientific Industrial Research Organisation) | AUSTRALIA |
| CSL Limited | AUSTRALIA |
| Curtin University | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Forensic Science SA | AUSTRALIA |
| GE Healthcare | UNITED STATES |
| Griffith University | AUSTRALIA |
| Institute of Medical and Veterinary Science | AUSTRALIA |
| La Trobe University | AUSTRALIA |
| Ludwig Institute for Cancer Research | AUSTRALIA |
| Macquarie University | AUSTRALIA |
| Martin-Luther University | GERMANY |
| Molecular Genetics | AUSTRALIA |
| Monash University | AUSTRALIA |
| National Taiwan University | TAIWAN |
| Peter MacCallum Cancer Centre | AUSTRALIA |
| Proteomics International | AUSTRALIA |
| Purdue University | UNITED STATES |
| Queen Elizabeth Hospital | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| Royal Brisbane and Women's Hospital | AUSTRALIA |
| Royal Children's Hospital, Victoria | AUSTRALIA |
| Royal Prince Alfred Hospital | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| Sechenov University | RUSSIAN FEDERATION |
| Sir Charles Gardiner Hospital | AUSTRALIA |
| St. Vincent's Institute of Medical Research | AUSTRALIA |
| Thammasat University | THAILAND |
| University of Adelaide | AUSTRALIA |
| University of California San Diego | UNITED STATES |
| University of Cambridge | UNITED KINGDOM |
| University of Dundee | UNITED KINGDOM |
| University of Düsseldorf | GERMANY |
| University of Leipzig | GERMANY |
| University of London | UNITED KINGDOM |
| University of Manchester | UNITED KINGDOM |
| University of Melbourne | AUSTRALIA |
| University of New South Wales | AUSTRALIA |
| University of North Carolina at Chapel Hill | UNITED STATES |
| University of North Texas | UNITED STATES |
| University of Queensland | AUSTRALIA |
| University of Rome Tor Vergata | ITALY |
| University of Science, Malaysia | MALAYSIA |
| University of South Australia | AUSTRALIA |
| University of Stuttgart | GERMANY |
| University of Sydney | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
| University of Western Australia | AUSTRALIA |
| Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
| Western Sydney University | AUSTRALIA |
| Women and Children's Health Research Institute | CANADA |
| Women's & Children's Health Research Institute Inc | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
Executive EditorJournal of Proteomics |
2020 |
Executive EditorJournal of Proteomics |
2019 |
Executive EditorJournal of Proteomics |
2018 |
Council MemberHUPO |
2017 |
Executive EditorJournal of Proteomics |
2017 |
Treasurer and Executive Committee MemberHuman Proteome Organization (HUPO) |
2017 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2016 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2016 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2016 |
Ad hoc grant assessorDFG |
2016 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2016 |
Council MemberHUPO |
2016 |
Guest EditorBiochimica et Biophysica Acta (BBA) |
2016 |
Invited presentationOURCON IV, Ustron, Poland |
2016 |
Keynote SpeakerHUPO, Taipei, Taiwan |
2016 |
Manuscript ReviewerAnalytical Chemistry |
2016 |
Manuscript ReviewerJournal of Chromatography A |
2016 |
Manuscript ReviewerJournal of Peptide Science |
2016 |
Manuscript ReviewerJournal of Proteome Research |
2016 |
Manuscript ReviewerJournal of Proteomics |
2016 |
Manuscript ReviewerMolecular and Cellular Proteomics |
2016 |
Manuscript ReviewerProteomics |
2016 |
Manuscript ReviewerRapid Communication in Mass Spectrometry |
2016 |
Manuscript ReviewerTalanta |
2016 |
SA representativeAustralasian Peptide Association |
2016 |
Vice PresidentAustralasian Proteomics Society |
2016 |
Vice President and Conference ChairLorne Proteomics Symposium |
2016 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2015 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2015 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2015 |
Ad hoc grant assessorDFG |
2015 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2015 |
Biochemistry Project Grant Review Panel MemberNational Health and Medical Research Council (NHMRC) |
2015 |
Council MemberHUPO |
2015 |
Invited presentationHUPO, Vancouver, Canada |
2015 |
Invited presentationOURCON III, Pisa, Italy |
2015 |
SA representativeAustralasian Peptide Association |
2015 |
Vice PresidentAustralasian Proteomics Society |
2015 |
Vice President and Conference ChairLorne Proteomics Symposium |
2015 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2014 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2014 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2014 |
Ad hoc grant assessorDFG |
2014 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2014 |
Invited presentationAnalytica, Munich Germany |
2014 |
Invited presentationOURCON II, Antalya, Turkey |
2014 |
SA representativeAustralasian Peptide Association |
2014 |
Session Chair and Session OrganiserAnalytica Conference Munich |
2014 |
Vice PresidentAustralasian Proteomics Society |
2014 |
Vice President and Conference ChairLorne Proteomics Symposium |
2014 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2013 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2013 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2013 |
Ad hoc grant assessorDFG |
2013 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2013 |
Invited presentationProteomics Forum, Berlin, Germany |
2013 |
Invited presentationProteomics Forum, Penang Malaysia |
2013 |
SA representativeAustralasian Peptide Association |
2013 |
Vice PresidentAustralasian Proteomics Society |
2013 |
Vice President and Conference ChairLorne Proteomics Symposium |
2013 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2012 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2012 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2012 |
Ad hoc grant assessorDFG |
2012 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2012 |
Invited presentation2nd Ovarian Cancer Symposium, Singapore |
2012 |
Invited presentationCanadian Proteomics Society meeting |
2012 |
Invited presentationOURCON I, Ourense, Spain |
2012 |
SA representativeAustralasian Peptide Association |
2012 |
Vice PresidentAustralasian Proteomics Society |
2012 |
Vice President and Conference ChairLorne Proteomics Symposium |
2012 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2011 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2011 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2011 |
Ad hoc grant assessorDFG |
2011 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2011 |
Invited presentationProteomics Forum, Berlin, Germany |
2011 |
SA representativeAustralasian Peptide Association |
2011 |
Session ChairLorne Proteomics Symposium |
2011 |
Session ChairAustralian Peptide Conference |
2011 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2010 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2010 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2010 |
Ad hoc grant assessorDFG |
2010 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2010 |
Invited presentationHUPO, Sydney, Australia |
2010 |
SA representativeAustralasian Peptide Association |
2010 |
Session ChairLorne Proteomics Symposium |
2010 |
Session ChairAustralian Peptide Conference |
2010 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2009 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2009 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2009 |
Ad hoc grant assessorDFG |
2009 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2009 |
Biochemistry Project Grant Review Panel MemberNational Health and Medical Research Council (NHMRC) |
2009 |
Directors InitiativeBio Innovation SA |
2009 |
SA representativeAustralasian Peptide Association |
2009 |
Session ChairLorne Proteomics Symposium |
2009 |
Session ChairAustralian Peptide Conference |
2009 |
Ad hoc grant assessorNational Health and Medical Research Council (NHMRC) |
2008 |
Ad hoc grant assessorAustralian Cancer Research Foundation |
2008 |
Ad hoc grant assessorAustralian Research Council (ARC) |
2008 |
Ad hoc grant assessorDFG |
2008 |
Ad hoc grant assessorRoyal Children Hospital Foundation |
2008 |
Directors InitiativeBio Innovation SA |
2008 |
SA representativeAustralasian Peptide Association |
2008 |
Session ChairLorne Proteomics Symposium |
2008 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Discovery of proteome changes that define the tissue pathology and structural progression of human knee osteoarthritis. | Current |
| Using high throughput screening to design cell therapy scaffolds | Completed |